165 Alberta AHCIP code: Malignant neoplasm of other and ill-defined sites within the respiratory system and intrathoracic organs
165 is the Alberta diagnostic code for “Malignant neoplasm of other and ill-defined sites within the respiratory system and intrathoracic organs” in Alberta Health’s January 2018 release, in effect from Jan 18, 2018.
Official description
165Malignant neoplasm of other and ill-defined sites within the respiratory system and intrathoracic organs
Alberta AHCIP diagnostic codes (ICD-9) · Alberta
More specific than 165
165 is a valid code on its own. When the note says more, one of these may fit better.
Notes for 165
Alberta Health’s list gives no includes, excludes or other notes for 165 or the headings above it.
Where 165 sits
- 1ChapterII. Neoplasms
- 2Block 160-165Malignant neoplasm of respiratory and intrathoracic organs
- 3Valid code 165Malignant neoplasm of other and ill-defined sites within the respiratory system and intrathoracic organs
Source and release
- Data release
- Alberta AHCIP · January 2018
- Effective date
- Jan 18, 2018
- Publisher
- Alberta Health
This page is built from the Alberta AHCIP catalog that Vero Codes reads when it suggests codes: Alberta Health’s January 2018 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does Alberta diagnostic code 165 mean?
165 is the Alberta diagnostic code for “Malignant neoplasm of other and ill-defined sites within the respiratory system and intrathoracic organs” in Alberta Health’s Alberta AHCIP January 2018 release.
Where is 165 in Alberta AHCIP?
165 sits under 160-165 Malignant neoplasm of respiratory and intrathoracic organs, within II. Neoplasms.
What coding notes apply to 165?
Alberta Health’s list gives no includes, excludes or other notes for 165 or the headings above it.
Which Alberta AHCIP release does this page use?
It uses Alberta Health’s January 2018 release, in effect from Jan 18, 2018. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.